| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Ovid Therapeutics Inc. | Director | Employee Stock Option (Right to Buy) | 65,000 | 26 Feb 2026 | Direct | ||
| Ovid Therapeutics Inc. | Director | Stock Option (right to buy) | 45,000 | 20 Feb 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| OVID | Ovid Therapeutics Inc. | 26 Feb 2026 | 1 | $0 | 4 | Director | 02 Mar 2026, 16:30 |
| OVID | Ovid Therapeutics Inc. | 20 Feb 2025 | 1 | $0 | 4 | Director | 18 Jun 2025, 16:45 |
| OVID | Ovid Therapeutics Inc. | 12 Dec 2024 | 1 | $0 | 4 | Director | 16 Dec 2024, 16:15 |
| OVID | Ovid Therapeutics Inc. | 22 Feb 2024 | 1 | $0 | 4 | Director | 26 Feb 2024, 17:57 |
| OVID | Ovid Therapeutics Inc. | 23 Feb 2023 | 1 | $0 | 4 | Director | 27 Feb 2023, 15:55 |
| OVID | Ovid Therapeutics Inc. | 08 Apr 2022 | 1 | $0 | 4 | Director | 12 Apr 2022, 17:53 |
| OVID | Ovid Therapeutics Inc. | 03 Feb 2022 | 1 | $0 | 4 | Director | 04 Feb 2022, 19:50 |
| OVID | Ovid Therapeutics Inc. | 11 Jun 2021 | 1 | $0 | 4 | Director | 11 Jun 2021, 20:22 |
| OVID | Ovid Therapeutics Inc. | 17 May 2021 | 1 | $0 | 4 | Director | 18 May 2021, 21:00 |